Pyrogen Testing Market : TOC

Table of Contents

1. Executive Summary

2. Introduction
   2.1. Pyrogen Testing Market Definition
   2.2. Pyrogen Testing Market Taxonomy

3. Pyrogen Testing Market Analysis Scenario 
   3.1. Market Size (US$ Mn) Value and Volume and Forecast
        3.1.1. Market Size and Y-o-Y Growth
        3.1.2. Absolute $ Opportunity
        3.1.3. Value Chain

4. Pyrogen Testing Market Dynamics
   4.1. Macro-economic Factors Affecting Global Pyrogen Testing Market
   4.2. Drivers
        4.2.1. Supply Side
        4.2.2. Demand Side
   4.3. Restraints
   4.4. Opportunity
   4.5. Forecast Factors – Relevance and Impact

5. Global Pyrogen Testing Market Analysis and Forecast, By Test Type
   5.1. Introduction - Definition
        5.1.1. Basis Point Share (BPS) Analysis By Test Type
        5.1.2. Y-o-Y Growth Projections By Test Type
   5.2. Market Size (US$ Mn) Value and Forecast By Test Type
        5.2.1. Recombinant Factor C Assay
        5.2.2. Monocyte Activation Assay
        5.2.3 Limulus Amebocyte Lysate
        5.2.4 Rabbit Pyrogen Test
   5.3. Market Attractiveness Analysis By Test Type

6. Global Pyrogen Testing Market Analysis and Forecast, By Application
   6.1. Introduction – Definition
        6.1.1. Basis Point Share (BPS) Analysis By Application
        6.1.2. Y-o-Y Growth Projections By Application
   6.2. Market Size (US$ Mn) Value and Forecast By Application
        6.2.1. Injections
        6.2.2. Vaccines
        6.2.3 Tablets
        6.2.4 Medical Devices
        6.2.5 Others
   6.3. Market Attractiveness Analysis By End User

7. Global Pyrogen Testing Market Analysis and Forecast, By End User
   7.1. Introduction – Definition
        7.1.1. Basis Point Share (BPS) Analysis By End User
        7.1.2. Y-o-Y Growth Projections By End User
   7.2. Market Size (US$ Mn) Value and Forecast By End User
        7.2.1. Pharmaceutical Industry
        7.2.2 Biotechnology Industry
        7.2.3 Medical Devices Industry
        7.2.4. Others
   7.3. Market Attractiveness Analysis By End User

8. Global Pyrogen Testing Market Analysis and Forecast, By Region
   8.1. Introduction
        8.1.1. Basis Point Share (BPS) Analysis By Region
        8.1.2. Y-o-Y Growth Projections By Region
   8.2. Market Size (US$ Mn) Value and Forecast By Region
        8.2.1. North America
        8.2.2. Latin America
        8.2.3. Europe
        8.2.4. APAC
        8.2.5. MEA
   8.3. Market Attractiveness Analysis By Region

9. North America Pyrogen Testing Market Analysis and Forecast
   9.1. Introduction
        9.1.1. Basis Point Share (BPS) Analysis
        9.1.2. Y-o-Y Growth Projections
   9.2. Market Size (US$ Mn) Value and Forecast By Test Type
        9.2.1. Recombinant Factor C Assay
        9.2.2. Monocyte Activation Assay
        9.2.3 Limulus Amebocyte Lysate
        9.2.4 Rabbit Pyrogen Test
   9.3. Market Size (US$ Mn) Value and Forecast By Application
        9.3.1. Injections
        9.3.2. Vaccines
        9.3.3 Tablets
        9.3.4 Medical Devices
        9.3.5 Others
   9.4. Market Size (US$ Mn) Value and Forecast By End User
        9.4.1. Pharmaceutical Industry
        9.4.2 Biotechnology Industry
        9.4.3 Medical Devices Industry
        9.4.4. Others
   9.5. Market Size (US$ Mn) Value and Forecast By Country
        9.5.1. U.S.
        9.5.2 Canada
   9.6. Market Attractiveness Analysis
        9.6.1. By Test Type
        9.6.2 By Application
        9.6.3 By End User

10. Latin America Pyrogen Testing Market Analysis and Forecast
   10.1. Introduction
        10.1.1. Basis Point Share (BPS) Analysis
        10.1.2. Y-o-Y Growth Projections
   10.2. Market Size (US$ Mn) Value and Forecast By Test Type
        10.2.1. Recombinant Factor C Assay
        10.2.2. Monocyte Activation Assay
        10.2.3 Limulus Amebocyte Lysate
        10.2.4 Rabbit Pyrogen Test
   10.3. Market Size (US$ Mn) Value and Forecast By Application
        10.3.1. Injections
        10.3.2. Vaccines
        10.3.3 Tablets
        10.3.4 Medical Devices
        10.3.5 Others
   10.4. Market Size (US$ Mn) Value and Forecast By End User
        10.4.1. Pharmaceutical Industry
        10.4.2 Biotechnology Industry
        10.4.3 Medical Devices Industry
        10.4.4. Others
   10.5. Market Size (US$ Mn) Value and Forecast By Country
        10.5.1. Argentina
        10.5.2 Brazil
        10.5.3 Mexico
        10.5.4 Rest of Latin America
   10.6. Market Attractiveness Analysis
        10.6.1. By Test Type
        10.6.2 By Application
        10.6.3 By End User

11. Europe Pyrogen Testing Market Analysis and Forecast
   11.1. Introduction
        11.1.1. Basis Point Share (BPS) Analysis
        11.1.2. Y-o-Y Growth Projections
   11.2. Market Size (US$ Mn) Value and Forecast By Test Type
        11.2.1. Recombinant Factor C Assay
        11.2.2. Monocyte Activation Assay
        11.2.3 Limulus Amebocyte Lysate
        11.2.4 Rabbit Pyrogen Test
   11.3. Market Size (US$ Mn) Value and Forecast By Application
        11.3.1. Injections
        11.3.2. Vaccines
        11.3.3 Tablets
        11.3.4 Medical Devices
        11.3.5 Others
   11.4. Market Size (US$ Mn) Value and Forecast By End User
        11.4.1. Pharmaceutical Industry
        11.4.2 Biotechnology Industry
        11.4.3 Medical Devices Industry
        11.4.4. Others
   11.5. Market Size (US$ Mn) Value and Forecast By Country
        11.5.1. Germany
        11.5.2 U.K.
        11.5.3. France
        11.5.4 Italy
        11.5.5. Spain
        11.5.6 Poland
        11.5.7. Russia
        11.5.8 Rest of Europe
   11.6. Market Attractiveness Analysis
        11.6.1. By Test Type
        11.6.2 By Application
        11.6.3 By End User

12. Asia Pacific Pyrogen Testing Market Analysis and Forecast
   12.1. Introduction
        12.1.1. Basis Point Share (BPS) Analysis
        12.1.2. Y-o-Y Growth Projections
   12.2. Market Size (US$ Mn) Value and Forecast By Test Type
        12.2.1. Recombinant Factor C Assay
        12.2.2. Monocyte Activation Assay
        12.2.3 Limulus Amebocyte Lysate
        12.2.4 Rabbit Pyrogen Test
   12.3. Market Size (US$ Mn) Value and Forecast By Application
        12.3.1. Injections
        12.3.2. Vaccines
        12.3.3 Tablets
        12.3.4 Medical Devices
        12.3.5 Others
   12.4. Market Size (US$ Mn) Value and Forecast By End User
        12.4.1. Pharmaceutical Industry
        12.4.2 Biotechnology Industry
        12.4.3 Medical Devices Industry
        12.4.4. Others
   12.5. Market Size (US$ Mn) Value and Forecast By Country
        12.5.1. China
        12.5.2 India
        12.5.3. Japan
        12.5.4 Australia & New Zealand
        12.5.5. Rest of Asia Pacific
   12.6. Market Attractiveness Analysis
        12.6.1. By Test Type
        12.6.2 By Application
        12.6.3 By End User

13. Middle East & Africa Pyrogen Testing Market Analysis and Forecast
   13.1. Introduction
        13.1.1. Basis Point Share (BPS) Analysis
        13.1.2. Y-o-Y Growth Projections
   13.2. Market Size (US$ Mn) Value and Forecast By Test Type
        13.2.1. Recombinant Factor C Assay
        13.2.2. Monocyte Activation Assay
        13.2.3 Limulus Amebocyte Lysate
        13.2.4 Rabbit Pyrogen Test
   13.3. Market Size (US$ Mn) Value and Forecast By Application
        13.3.1. Injections
        13.3.2. Vaccines
        13.3.3 Tablets
        13.3.4 Medical Devices
        13.3.5 Others
   13.4. Market Size (US$ Mn) Value and Forecast By End User
        13.4.1. Pharmaceutical Industry
        13.4.2 Biotechnology Industry
        13.4.3 Medical Devices Industry
        13.4.4. Others
   13.5. Market Size (US$ Mn) Value and Forecast By Country
        13.5.1. GCC Countries
        13.5.2 South Africa
        13.5.3 Rest of MEA
   13.6. Market Attractiveness Analysis
        13.6.1. By Test Type
        13.6.2 By Application
        13.6.3 By End User

14. Competitive Landscape
   14.1. Competition Dashboard
   14.2. Company Share Analysis
   14.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
        14.3.1 Thermo Fisher Scientific, Inc. 
        14.3.2 Merck & Co., Inc. 
        14.3.3 Associates of Cape Cod, Inc.
        14.3.4 Charles River Laboratories International, Inc. 
        14.3.5 GenScript 
        14.3.6 Lonza Group 
        14.3.7 Hyglos GmbH 
        14.3.8 Wako Chemicals USA, Inc. 
        14.3.9 Microcoat Biotechnologie GmbH 

15. Research Methodology

16. Assumptions and Acronyms Use